Low-dose aspirin for primary and secondary prevention of cardiovascular events in Denmark 1998–2018

Abstract Randomised controlled trials have shown a neutral or even unfavourable risk–benefit balance of aspirin for primary prevention of cardiovascular events. Using Danish nationwide registries, we investigated aspirin use and associated risks during the past two decades (1998–2018). We linked ind...

Full description

Saved in:
Bibliographic Details
Main Authors: Mikkel B. Christensen, Espen Jimenez-Solem, Martin. T. Ernst, Morten Schmidt, Anton Pottegård, Erik L. Grove
Format: article
Language:EN
Published: Nature Portfolio 2021
Subjects:
R
Q
Online Access:https://doaj.org/article/b2be06933ec84314ab22e613f81050c2
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items